These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7685747)

  • 1. Lower prevalence of anti-hepatitis C antibody in dialysis and renal transplant patients in Ireland.
    Conlon PJ; Walshe JJ; Smyth EG; McNamara EB; Donohoe J; Carmody M
    Ir J Med Sci; 1993 Apr; 162(4):145-7. PubMed ID: 7685747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of antibodies to hepatitis C virus among Omani patients with renal disease.
    al-Dhahry SH; Aghanashinikar PN; al-Hasani MK; Buhl MR; Daar AS
    Infection; 1993; 21(3):164-7. PubMed ID: 7690010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission.
    Conway M; Catterall AP; Brown EA; Tibbs C; Gower PE; Curtis JR; Coleman JC; Murray-Lyon IM
    Nephrol Dial Transplant; 1992; 7(12):1226-9. PubMed ID: 1283447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on hepatitis C virus infection in haemodialysis patients].
    Koda T; Tamura I; Ichimura H; Kurimura O
    Kansenshogaku Zasshi; 1992 Jan; 66(1):66-9. PubMed ID: 1328419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients.
    Yamaguchi K; Kiyokawa H; Machida J; Obayashi A; Nojiri N; Ueda S; Takatsuki K
    FEMS Microbiol Rev; 1994 Jul; 14(3):253-8. PubMed ID: 7522023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of non-A non-B hepatitis and anti-HCV antibodies in a Portuguese dialysis population.
    Carrera F; Silva JG; Pires C; Oliveira C
    Nephrol Dial Transplant; 1992; 7(9):913-6. PubMed ID: 1383874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission.
    Cendoroglo Neto M; Draibe SA; Silva AE; Ferraz ML; Granato C; Pereira CA; Sesso RC; Gaspar AM; Ajzen H
    Nephrol Dial Transplant; 1995; 10(2):240-6. PubMed ID: 7538651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus infection during haemodialysis in India.
    Agarwal SK; Dash SC; Irshad M
    J Assoc Physicians India; 1999 Dec; 47(12):1139-43. PubMed ID: 11225211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of antibodies to hepatitis C virus in a Dutch group of haemodialysis patients related to risk factors.
    Schneeberger PM; Vos J; van Dijk WC
    J Hosp Infect; 1993 Dec; 25(4):265-70. PubMed ID: 7510734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus infection in renal dialysis patients in Glasgow.
    McIntyre PG; McCruden EA; Dow BC; Cameron SO; McMillan MA; Allison ME; Briggs JD
    Nephrol Dial Transplant; 1994; 9(3):291-5. PubMed ID: 7519762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and significance of antibodies to hepatitis C virus among Saudi haemodialysis patients.
    Ayoola EA; Huraib S; Arif M; al-Faleh FZ; al-Rashed R; Ramia S; al-Mofleh IA; Abu-Aisha H
    J Med Virol; 1991 Nov; 35(3):155-9. PubMed ID: 1725179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
    Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
    Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of hepatitis C virus infection among renal transplant recipients.
    Chan TM; Lok AS; Cheng IK; Chan RT
    Gastroenterology; 1993 Mar; 104(3):862-8. PubMed ID: 7680019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center.
    Selgas R; Martinez-Zapico R; Bajo MA; Romero JR; Munoz J; Rinon C; Miranda B; Miguel JL
    Perit Dial Int; 1992; 12(1):28-30. PubMed ID: 1311962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey.
    Sauné K; Kamar N; Miédougé M; Weclawiak H; Dubois M; Izopet J; Rostaing L
    Nephrol Dial Transplant; 2011 Jul; 26(7):2309-16. PubMed ID: 21097646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal alanine aminotransferase activity reflects exposure to hepatitis C virus in haemodialysis patients.
    Mondelli MU; Smedile V; Piazza V; Villa G; Barbieri C; Gattarello G; Mancini F; Raimondo G
    Nephrol Dial Transplant; 1991; 6(7):480-3. PubMed ID: 1717892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients.
    Huang CC; Liaw YF; Lai MK; Chu SH; Chuang CK; Huang JY
    Transplantation; 1992 Apr; 53(4):763-5. PubMed ID: 1373534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against hepatitis C virus among renal transplant patients in Greece.
    Boletis J; Stathakis C; Papastathi H; Vafiadi I; Goumenos D; Miriagou B; Hatzakis A; Kostakis A; Vosnides G
    Transpl Int; 1992; 5 Suppl 1():S51-3. PubMed ID: 14621730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and role of hepatitis C viraemia in haemodialysis patients in Japan.
    Hayashi J; Nakashima K; Yoshimura E; Kishihara Y; Ohmiya M; Hirata M; Kashiwagi S
    J Infect; 1994 May; 28(3):271-7. PubMed ID: 7522260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.